Legend Biotech Announces Participation in Upcoming Investor Conferences
February 24 2023 - 8:30AM
Business Wire
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a
global biotechnology company developing, manufacturing and
commercializing novel therapies to treat life-threatening diseases,
today announced its participation in the upcoming investor
conferences:
Event: Cowen 43rd Annual Healthcare Conference
Location: Boston, MA Fireside Chat Date & Time:
Tuesday, March 7, 2023 at 9:50am ET Presenter: Ying Huang,
Ph.D., CEO
Event: Barclays Global Healthcare Conference
Location: Miami, FL Fireside Chat Date & Time:
Tuesday, March 14, 2023 at 10:15am ET Presenter: Ying Huang,
Ph.D., CEO
About Legend Biotech Legend Biotech is a global
biotechnology company dedicated to treating, and one day curing,
life-threatening diseases. Headquartered in Somerset, New Jersey,
we are developing advanced cell therapies across a diverse array of
technology platforms, including autologous and allogenic chimeric
antigen receptor T-cell and natural killer (NK) cell-based
immunotherapy. From our three R&D sites around the world, we
apply these innovative technologies to pursue the discovery of
cutting-edge therapeutics for patients worldwide.
Learn more at www.legendbiotech.com and follow us on Twitter and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230224005077/en/
Press Contact: Tina Carter, Corporate Communications
Lead, Legend Biotech tina.carter@legendbiotech.com (908)
331-5025
Investor Contacts: Joanne Choi, Senior Manager, Investor
Relations, Legend Biotech joanne.choi@legendbiotech.com
Crystal Chen, Manager, Investor Relations, Legend Biotech
crystal.chen@legendbiotech.com
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Apr 2023 to Apr 2024